Department of Neurology, West China Hospital of Sichuan University, Chengdu, China.
Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Mov Disord. 2022 Jun;37(6):1256-1264. doi: 10.1002/mds.28973. Epub 2022 Mar 8.
Patients with dementia with Lewy bodies (DLB) may have overlapping Alzheimer's disease pathology. We investigated the longitudinal rate of tau accumulation and its association with neurodegeneration and clinical disease progression in DLB.
Consecutive patients with probable DLB (n = 22) from the Mayo Clinic Alzheimer's Disease Research Center and age-matched and sex-matched cognitively unimpaired controls (CU; n = 22) with serial magnetic resonance imaging and flortaucipir positron emission tomography scans within an average of 1.6 years were included. Regional annualized rates of flortaucipir uptake standardized uptake value ratios (SUVr) were calculated. Regional annualized rates of cortical volume change were measured with the Tensor Based Morphometry-Syn algorithm.
The annual increase of flortaucipir SUVr was greater in the middle and superior occipital, fusiform, and inferior parietal cortices in DLB (mean: 0.017, 0.019, 0.019, and 0.015, respectively) compared with the CU (mean: -0.006, -0.009, -0.003, and - 0.005, respectively; P < 0.05). In patients with DLB (but not the CU), a longitudinal increase in flortaucipir SUVr was associated with longitudinal cortical atrophy rates in the lateral occipital and inferior temporoparietal cortices, hippocampus, and the temporal pole as well as a concurrent decline on Mini-Mental State Examination and Clinical Dementia Rating-Sum of Boxes in the lateral occipital and the fusiform cortices.
Tau accumulation was faster in DLB compared with the CU, with increased accumulation rates in the lateral occipital and temporoparietal cortices. These increased rates of tau accumulation were associated with neurodegeneration and faster disease progression in DLB. Tau may be a potential treatment target in a subset of patients with DLB. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
路易体痴呆(DLB)患者可能存在阿尔茨海默病病理学的重叠。我们研究了 tau 积聚的纵向速率及其与 DLB 中的神经退行性变和临床疾病进展的关系。
连续纳入来自梅奥诊所阿尔茨海默病研究中心的可能 DLB 患者(n=22)和年龄匹配、性别匹配的认知正常对照者(CU;n=22),在平均 1.6 年内进行连续磁共振成像和 flortaucipir 正电子发射断层扫描。计算 flortaucipir 摄取标准化摄取值比(SUVr)的区域年化率。使用基于张量的形态学-Syn 算法测量皮质体积变化的区域年化率。
与 CU(平均分别为-0.006、-0.009、-0.003 和-0.005)相比,DLB 患者中中、上枕叶、梭状回和下顶叶皮质的 flortaucipir SUVr 年增长率更高(平均分别为 0.017、0.019、0.019 和 0.015,P<0.05)。在 DLB 患者中(但不是 CU),flortaucipir SUVr 的纵向增加与外侧枕叶和下颞顶叶皮质、海马体和颞极的皮质萎缩率以及外侧枕叶和梭状回的 Mini-Mental State Examination 和临床痴呆评定总和的同时下降有关。
与 CU 相比,DLB 中的 tau 积聚更快,外侧枕叶和颞顶叶皮质的积聚率增加。这些 tau 积聚率的增加与 DLB 中的神经退行性变和更快的疾病进展有关。tau 可能是 DLB 患者亚群的潜在治疗靶点。